X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs SUVEN LIFE - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS SUVEN LIFE IPCA LABS/
SUVEN LIFE
 
P/E (TTM) x 36.6 16.1 228.2% View Chart
P/BV x 3.5 3.8 91.2% View Chart
Dividend Yield % 0.1 0.5 32.2%  

Financials

 IPCA LABS   SUVEN LIFE
EQUITY SHARE DATA
    IPCA LABS
Mar-17
SUVEN LIFE
Mar-17
IPCA LABS/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs643229 281.4%   
Low Rs503151 332.8%   
Sales per share (Unadj.) Rs254.442.7 595.8%  
Earnings per share (Unadj.) Rs16.16.9 234.6%  
Cash flow per share (Unadj.) Rs29.88.5 349.0%  
Dividends per share (Unadj.) Rs1.001.00 100.0%  
Dividend yield (eoy) %0.20.5 33.1%  
Book value per share (Unadj.) Rs194.652.4 371.3%  
Shares outstanding (eoy) m126.20127.28 99.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.34.4 50.7%   
Avg P/E ratio x35.727.7 128.7%  
P/CF ratio (eoy) x19.222.2 86.5%  
Price / Book Value ratio x2.93.6 81.3%  
Dividend payout %6.214.6 42.6%   
Avg Mkt Cap Rs m72,30024,158 299.3%   
No. of employees `00013.31.0 1,309.4%   
Total wages/salary Rs m6,960522 1,334.1%   
Avg. sales/employee Rs Th2,413.55,349.7 45.1%   
Avg. wages/employee Rs Th523.2513.5 101.9%   
Avg. net profit/employee Rs Th152.4858.1 17.8%   
INCOME DATA
Net Sales Rs m32,1065,435 590.7%  
Other income Rs m226211 107.0%   
Total revenues Rs m32,3325,646 572.6%   
Gross profit Rs m4,4481,291 344.6%  
Depreciation Rs m1,730214 807.8%   
Interest Rs m24157 423.9%   
Profit before tax Rs m2,7031,231 219.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675359 188.2%   
Profit after tax Rs m2,028872 232.6%  
Gross profit margin %13.923.7 58.3%  
Effective tax rate %25.029.2 85.7%   
Net profit margin %6.316.0 39.4%  
BALANCE SHEET DATA
Current assets Rs m17,3404,917 352.6%   
Current liabilities Rs m9,5591,186 806.0%   
Net working cap to sales %24.268.6 35.3%  
Current ratio x1.84.1 43.8%  
Inventory Days Days10062 161.4%  
Debtors Days Days5731 184.8%  
Net fixed assets Rs m20,7793,154 658.7%   
Share capital Rs m252127 198.3%   
"Free" reserves Rs m24,4996,543 374.4%   
Net worth Rs m24,5536,670 368.1%   
Long term debt Rs m3,517259 1,356.5%   
Total assets Rs m39,5958,157 485.4%  
Interest coverage x12.222.7 53.9%   
Debt to equity ratio x0.10 368.5%  
Sales to assets ratio x0.80.7 121.7%   
Return on assets %5.711.4 50.3%  
Return on equity %8.313.1 63.2%  
Return on capital %10.518.6 56.4%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Exports (fob) Rs m15,617NA-   
Imports (cif) Rs m4,571NA-   
Fx inflow Rs m15,6174,996 312.6%   
Fx outflow Rs m5,828959 607.7%   
Net fx Rs m9,7904,037 242.5%   
CASH FLOW
From Operations Rs m2,7641,088 254.0%  
From Investments Rs m-1,432-3,107 46.1%  
From Financial Activity Rs m-1,591-300 530.1%  
Net Cashflow Rs m-259-2,319 11.2%  

Share Holding

Indian Promoters % 45.9 63.4 72.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 0.0 -  
FIIs % 25.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 36.5 47.7%  
Shareholders   36,892 37,287 98.9%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   STRIDES SHASUN LTD  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6%

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 19, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS